書報討論
| 報告日期 | 報告題目 | 報告人 | |
|---|---|---|---|
| 2026-03-27 | Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial | 邱思晴 | |
| 2026-03-27 | USP15 regulates radiation-induced DNA damage and intestinal injury through K48- linked deubiquitination and stabilisation of ATM | 張哲維 | |
| 2026-03-27 | Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer | 周嘉慧 | |
| 2026-03-20 | HIF regulates multiple translated endogenous retroviruses: Implications for cancer immunotherapy | 邵小嘉 | |
| 2026-03-20 | Innovative dual-gene delivery platform using miR-124 and PD-1 via umbilical cord mesenchymal stem cells and exosome for glioblastoma therapy | 張洛薇 | |
| 2026-03-20 | Whole-genome landscapes of 1,364 breast cancers | 張于婷 | |
| 2026-03-13 | CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells | 呂祥瑜 | |
| 2026-03-13 | argeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosi | 高士耕 | |
| 2026-03-13 | “Sample-in, result-out” liquid biopsy chip based on immunomagnetic separation and CRISPR detection for multiplex analysis of exosomal microRNAs | 吳柏嶔 | |
| 2026-03-13 | Galectin-3 exacerbates autoimmune diabetes by limiting regulatory T cell differentiation and function | 劉千瑜 |
